{"id":2022,"date":"2023-06-19T09:31:58","date_gmt":"2023-06-19T13:31:58","guid":{"rendered":"https:\/\/happylungsproject.org\/?p=2022"},"modified":"2026-03-02T10:53:35","modified_gmt":"2026-03-02T15:53:35","slug":"two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting","status":"publish","type":"post","link":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/","title":{"rendered":"Two research studies funded by HLP presented at 2023 ASCO Mtg"},"content":{"rendered":"[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none” column_shadow=”none” column_border_radius=”none” column_link_target=”_self” column_position=”default” gradient_direction=”left_to_right” overlay_strength=”0.3″ width=”1\/1″ tablet_width_inherit=”default” animation_type=”default” bg_image_animation=”none” border_type=”simple” column_border_width=”none” column_border_style=”solid”][divider line_type=”No Line” custom_height=”20″][vc_column_text]Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention. Two research studies funded by The Happy Lungs Project were presented at ASCO.<\/p>\n

Dr. Jessica Lin<\/h2>\n

First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.<\/h3>\n

Abstract #9065<\/strong>. There are currently 2 FDA-approved therapies for RET lung cancer, selpercatinib and pralsetinib that target specifically RET, but unfortunately within 1-3 years, many patients become resistant to the therapies and the cancer progress again. In an effort to understand the mechanisms of resistance to RET therapies, Dr. Lin\u2019s team performed an analysis of 103 biopsies obtained from 88 patients who progressed on a RET inhibitor.<\/p>\n

The analysis demonstrated that resistance to RET inhibition can happen by acquired mutations in the RET gene identified in 14% of the patients. Interestingly, they showed that the majority of RET inhibitor resistance is mediated by bypass mechanisms such as activation of alternative pathways in the tumors. This mechanism was found in 42% of patients with amplification of the MET gene being the most common one (14% of patients).<\/p>\n

This study points out the urgent need of finding new therapies or more effective combinations for RET inhibitor resistance that is mediated by activation of alternative pathways.<\/p>\n

Download Final Results from the RETgistry here<\/a><\/strong>.[\/vc_column_text][image_with_animation image_url=”2023″ image_size=”full” animation_type=”entrance” animation=”None” animation_movement_type=”transform_y” hover_animation=”none” alignment=”” img_link_large=”yes” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default”][vc_column_text]\n

\n
\n
\n

Reference: Alissa Jamie Cooper, Alexander E. Drilon, Julia K. Rotow, Stephen V. Liu, Oliver Gautschi, Katherine Emilie Rhoades Smith, Dae Ho Lee, Misako Nagasaka, Herbert H. F. Loong, Nathan A. Pennell, Jyoti D. Patel, Martin Fru\u0308h, Benjamin J. Solomon, Georg Pall, Natalie F. Uy, Jonathan W. Riess, Lori J. Wirth, Beow Y. Yeap, Justin F. Gainor, and Jessica Jiyeong Lin Journal of Clinical Oncology 2023 41:16_suppl, 9065-9065<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n[\/vc_column_text][divider line_type=”No Line” custom_height=”20″][vc_column_text]\n

\n
\n
\n

Drs. John Heymach (MDACC) and Ralf Kittler (UTSW)<\/h2>\n

Genomic mechanisms of RET inhibitor sensitivity and resistance in RET-fusion positive cancer cells.<\/h3>\n

Abstract #e21029<\/strong>. Resistance to RET therapies can happen by acquired mutations in the RET gene which can develop in people and cause resistance to RET inhibitors. Drs. Heymach and Kittler\u2019s teams published data from the LentiMutate approach, an innovative approach that aims to identify drug resistance acquired mutations in the RET gene before they happen in patients. They were able to identify the G810S RET mutation that was associated with acquired resistance to both RET inhibitors selpercatinib and pralsetinib in RET cancer cells, consistent with prior reports. Importantly, they also identified the V804M\/E and M918T mutations that were associated with acquired resistance to the RET inhibitor selpercatinib but not pralsetinib, and L730I\/V and E732K mutations that were associated with resistance to pralsetinib but not selpercatinib.<\/p>\n

This study demonstrates that individual RET fusion lung cancer variants have distinct drug sensitivity profiles and that acquired resistance mutations may be non-overlapping between the RET inhibitors.<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n

\n
\n

Reference: John Heymach, Monique B. Nilsson, Xiaofang Huo, Ashwani Kumar, Jun He, and Ralf Kittler. Journal of Clinical Oncology 2023 41:16_suppl, e21029-e21029<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n[\/vc_column_text][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” scene_position=”center” text_color=”dark” text_align=”left” row_border_radius=”none” row_border_radius_applies=”bg” overflow=”visible” overlay_strength=”0.3″ gradient_direction=”left_to_right” shape_divider_position=”bottom” bg_image_animation=”none” shape_type=””][vc_column column_padding=”no-extra-padding” column_padding_tablet=”inherit” column_padding_phone=”inherit” column_padding_position=”all” column_element_direction_desktop=”default” column_element_spacing=”default” desktop_text_alignment=”default” tablet_text_alignment=”default” phone_text_alignment=”default” background_color_opacity=”1″ background_hover_color_opacity=”1″ column_backdrop_filter=”none”…<\/p>\n","protected":false},"author":15,"featured_media":2023,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,20],"tags":[],"class_list":{"0":"post-2022","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-research","8":"category-treatment"},"yoast_head":"\nTwo research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project<\/title>\n<meta name=\"description\" content=\"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Two research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project\" \/>\n<meta property=\"og:description\" content=\"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"The Happy Lungs Project\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/thehappylungsproject\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-19T13:31:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-02T15:53:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"544\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Irene Guijarro Munoz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Irene Guijarro Munoz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\"},\"author\":{\"name\":\"Irene Guijarro Munoz\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\"},\"headline\":\"Two research studies funded by HLP presented at 2023 ASCO Mtg\",\"datePublished\":\"2023-06-19T13:31:58+00:00\",\"dateModified\":\"2026-03-02T15:53:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\"},\"wordCount\":750,\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg\",\"articleSection\":[\"Research\",\"Treatment\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\",\"url\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\",\"name\":\"Two research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project\",\"isPartOf\":{\"@id\":\"https:\/\/happylungsproject.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg\",\"datePublished\":\"2023-06-19T13:31:58+00:00\",\"dateModified\":\"2026-03-02T15:53:35+00:00\",\"description\":\"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.\",\"breadcrumb\":{\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg\",\"width\":1200,\"height\":544,\"caption\":\"on and off target ret resistance\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/happylungsproject.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Two research studies funded by HLP presented at 2023 ASCO Mtg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/happylungsproject.org\/#website\",\"url\":\"https:\/\/happylungsproject.org\/\",\"name\":\"The Happy Lungs Project\",\"description\":\"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.\",\"publisher\":{\"@id\":\"https:\/\/happylungsproject.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/happylungsproject.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/happylungsproject.org\/#organization\",\"name\":\"The Happy Lungs Project\",\"url\":\"https:\/\/happylungsproject.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"contentUrl\":\"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png\",\"width\":1500,\"height\":1575,\"caption\":\"The Happy Lungs Project\"},\"image\":{\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/thehappylungsproject\",\"https:\/\/www.instagram.com\/thehappylungsproject\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b\",\"name\":\"Irene Guijarro Munoz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g\",\"caption\":\"Irene Guijarro Munoz\"},\"description\":\"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.\",\"sameAs\":[\"https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Two research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project","description":"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Two research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project","og_description":"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.","og_url":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/","og_site_name":"The Happy Lungs Project","article_publisher":"https:\/\/www.facebook.com\/thehappylungsproject","article_published_time":"2023-06-19T13:31:58+00:00","article_modified_time":"2026-03-02T15:53:35+00:00","og_image":[{"width":1200,"height":544,"url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg","type":"image\/jpeg"}],"author":"Irene Guijarro Munoz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Irene Guijarro Munoz","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/"},"author":{"name":"Irene Guijarro Munoz","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b"},"headline":"Two research studies funded by HLP presented at 2023 ASCO Mtg","datePublished":"2023-06-19T13:31:58+00:00","dateModified":"2026-03-02T15:53:35+00:00","mainEntityOfPage":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/"},"wordCount":750,"publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"image":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg","articleSection":["Research","Treatment"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/","url":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/","name":"Two research studies funded by HLP presented at 2023 ASCO Mtg - The Happy Lungs Project","isPartOf":{"@id":"https:\/\/happylungsproject.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg","datePublished":"2023-06-19T13:31:58+00:00","dateModified":"2026-03-02T15:53:35+00:00","description":"Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The six-day meeting brought together more than 40,000 people in cancer research, care, and advocacy to discover the latest innovations in cancer research, treatment, and prevention.","breadcrumb":{"@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#primaryimage","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2023\/06\/on-and-off-target-ret-resistance.jpg","width":1200,"height":544,"caption":"on and off target ret resistance"},{"@type":"BreadcrumbList","@id":"https:\/\/happylungsproject.org\/two-research-studies-funded-by-hlp-were-presented-at-2023-asco-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/happylungsproject.org\/"},{"@type":"ListItem","position":2,"name":"Two research studies funded by HLP presented at 2023 ASCO Mtg"}]},{"@type":"WebSite","@id":"https:\/\/happylungsproject.org\/#website","url":"https:\/\/happylungsproject.org\/","name":"The Happy Lungs Project","description":"Finding dependable treatments and ultimately a cure for RET Positive NSCLC.","publisher":{"@id":"https:\/\/happylungsproject.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/happylungsproject.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/happylungsproject.org\/#organization","name":"The Happy Lungs Project","url":"https:\/\/happylungsproject.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/","url":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","contentUrl":"https:\/\/happylungsproject.org\/wp-content\/uploads\/2021\/07\/HAPPY-LUNGS-LOGOS_stacked-full-color-e1632760868380.png","width":1500,"height":1575,"caption":"The Happy Lungs Project"},"image":{"@id":"https:\/\/happylungsproject.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/thehappylungsproject","https:\/\/www.instagram.com\/thehappylungsproject\/"]},{"@type":"Person","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/7f7dfd38ae877d303fc9831b49693d4b","name":"Irene Guijarro Munoz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/happylungsproject.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b203420602dc287c938d2e2de2a2da59b7a2f94264288a3f345af4be6737c07a?s=96&d=mm&r=g","caption":"Irene Guijarro Munoz"},"description":"Irene Guijarro Munoz, Director of Research Irene Guijarro Munoz joined the Happy Lungs Project (HLP) as Director of Research in 2022. She oversees and coordinates the RET research program at HLP, including the studies that are currently being funded by HLP and conducted at four major US cancer centers. She assists with the development of RET research funding proposals and coordinates collaborations between the academic investigators and commercial contractors. In addition, she helps lung cancer patients and their families in the understanding of the RET positive lung cancer biology and the potential treatment options available. She has a scientific background and she completed a PhD in Biochemistry, Molecular Biology and Biomedicine, a Master of Biotechnology, and a Bachelor\u2019s Degree in Biochemistry at Universidad Aut\u00f3noma de Madrid, Spain, where she is originally from.","sameAs":["https:\/\/happylungsproject.org\/irene-our-director-of-ret-lung-cancer-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/comments?post=2022"}],"version-history":[{"count":5,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2022\/revisions"}],"predecessor-version":[{"id":2705,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/posts\/2022\/revisions\/2705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media\/2023"}],"wp:attachment":[{"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/media?parent=2022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/categories?post=2022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/happylungsproject.org\/wp-json\/wp\/v2\/tags?post=2022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}